Literature DB >> 10560035

A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression.

J C Nelson1.   

Abstract

Both norepinephrine and serotonin mediate the effects of antidepressant drugs and a reasonable question is whether the efficacy of these two mechanisms of action is similar. Previous reviews comparing selective serotonergic drugs with tricyclic antidepressants found no differences, but the tricyclic drugs are heterogeneous with respect to mechanism of action. The current review focuses on studies comparing serotonergic agents with antidepressants that act primarily on norepinephrine. The literature was reviewed to identify double-blind, random assignment studies comparing SSRIs and NRIs, with adequate description of methods and outcome. Fifteen studies were identified, which had enrolled a total of over 1500 patients. The rates of response with SSRIs and NRIs, 61.4% and 59.5%, were neither meaningfully nor significantly different. Few predictors of response were identified in these studies. Noradrenergic and serotonergic antidepressants appear to be equally effective. It remains to be determined if they treat the same or different patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10560035     DOI: 10.1016/s0006-3223(99)00173-0

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

Review 1.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

2.  Prior cold water swim stress alters immobility in the forced swim test and associated activation of serotonergic neurons in the rat dorsal raphe nucleus.

Authors:  R C Drugan; P T Hibl; K J Kelly; K F Dady; M W Hale; C A Lowry
Journal:  Neuroscience       Date:  2013-08-31       Impact factor: 3.590

3.  Gene expression profiling and its practice in drug development.

Authors:  Murty V Chengalvala; Vargheese M Chennathukuzhi; Daniel S Johnston; Panayiotis E Stevis; Gregory S Kopf
Journal:  Curr Genomics       Date:  2007-06       Impact factor: 2.236

4.  Chronic desipramine treatment alters tyrosine hydroxylase but not norepinephrine transporter immunoreactivity in norepinephrine axons in the rat prefrontal cortex.

Authors:  Susan L Erickson; Anjalika R Gandhi; Josephine K Asafu-Adjei; Allan R Sampson; LeeAnn Miner; Randy D Blakely; Susan R Sesack
Journal:  Int J Neuropsychopharmacol       Date:  2011-01-06       Impact factor: 5.176

5.  Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Jenna Ford; Jessica A Rogers; Stacey Scheick; Yue Ji; Mahendra Bishnoi; Jon C Alexander
Journal:  Pharmacol Biochem Behav       Date:  2011-12-09       Impact factor: 3.533

6.  Taste responses in patients with Parkinson's disease.

Authors:  H Sienkiewicz-Jarosz; A Scinska; W Kuran; D Ryglewicz; A Rogowski; E Wrobel; A Korkosz; A Kukwa; W Kostowski; P Bienkowski
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-01       Impact factor: 10.154

7.  Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study.

Authors:  Tomohiro Kobayashi; Etsuko Hayashi; Midori Shimamura; Mine Kinoshita; Niall P Murphy
Journal:  Psychopharmacology (Berl)       Date:  2008-02-15       Impact factor: 4.530

Review 8.  Regulation of antidepressant activity by cAMP response element binding proteins.

Authors:  Alana C Conti; Julie A Blendy
Journal:  Mol Neurobiol       Date:  2004-10       Impact factor: 5.590

9.  Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.

Authors:  Mei Huang; Junji Ichiwaka; Zhu Li; Jin Dai; Herbert Y Meltzer
Journal:  Psychopharmacology (Berl)       Date:  2006-03-07       Impact factor: 4.530

10.  alpha(1A)- and alpha(1B)-adrenergic receptors differentially modulate antidepressant-like behavior in the mouse.

Authors:  Van A Doze; Evelyn M Handel; Kelly A Jensen; Belle Darsie; Elizabeth J Luger; James R Haselton; Jeffery N Talbot; Boyd R Rorabaugh
Journal:  Brain Res       Date:  2009-06-18       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.